These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1604 related items for PubMed ID: 9118586

  • 1. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG, Berstad A.
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [Abstract] [Full Text] [Related]

  • 2. Acid pump inhibitors. The treatment of gastroesophageal reflux.
    Hetzel D.
    Aust Fam Physician; 1998 Jun; 27(6):487-91. PubMed ID: 9648315
    [Abstract] [Full Text] [Related]

  • 3. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD, Wilde MI.
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [Abstract] [Full Text] [Related]

  • 4. The medical therapy of reflux oesophagitis.
    Tytgat GN, Nio CY.
    Baillieres Clin Gastroenterol; 1987 Oct; 1(4):791-807. PubMed ID: 2896523
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC, Festen HP, Meuwissen SG.
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [Abstract] [Full Text] [Related]

  • 6. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM, Prakash A, Faulds D, Lamb HM.
    Drugs; 2003 May; 63(1):101-33. PubMed ID: 12487624
    [Abstract] [Full Text] [Related]

  • 7. Drug therapy of reflux oesophagitis: an update.
    Tytgat GN.
    Scand J Gastroenterol Suppl; 1989 May; 168():38-49. PubMed ID: 2575792
    [Abstract] [Full Text] [Related]

  • 8. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 9. Night-time gastro-oesophageal reflux disease: prevalence, hazards, and management.
    Orr WC.
    Eur J Gastroenterol Hepatol; 2005 Jan; 17(1):113-20. PubMed ID: 15647651
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological treatment of children with gastro-oesophageal reflux.
    Tighe M, Afzal NA, Bevan A, Hayen A, Munro A, Beattie RM.
    Cochrane Database Syst Rev; 2014 Nov 24; 2014(11):CD008550. PubMed ID: 25419906
    [Abstract] [Full Text] [Related]

  • 11. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A, Wiseman L.
    Drugs; 1996 Mar 24; 51(3):460-82. PubMed ID: 8882382
    [Abstract] [Full Text] [Related]

  • 12. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Mar 24; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 13. Shortcomings of the first-generation proton pump inhibitors.
    Tytgat GN.
    Eur J Gastroenterol Hepatol; 2001 May 24; 13 Suppl 1():S29-33. PubMed ID: 11430506
    [Abstract] [Full Text] [Related]

  • 14. Drugs, bugs, and esophageal pH profiles.
    Robinson M.
    Yale J Biol Med; 1999 May 24; 72(2-3):169-72. PubMed ID: 10780578
    [Abstract] [Full Text] [Related]

  • 15. The diagnosis and management of gastro-oesophageal reflux in infants.
    Vandenplas Y, Salvatore S, Hauser B.
    Early Hum Dev; 2005 Dec 24; 81(12):1011-24. PubMed ID: 16278060
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience with pantoprazole in gastroesophageal reflux disease.
    Avner DL.
    Clin Ther; 2000 Oct 24; 22(10):1169-85; discussion 1149-50. PubMed ID: 11110229
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH, de K Grundling H, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fischer R, Bethke T.
    Eur J Gastroenterol Hepatol; 2000 Feb 24; 12(2):197-202. PubMed ID: 10741935
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T.
    Clin Pharmacokinet; 1996 Jul 24; 31(1):9-28. PubMed ID: 8827397
    [Abstract] [Full Text] [Related]

  • 19. Treatment of gastroesophageal (acid) reflux with lansoprazole: an overview.
    Dobrilla G, Di Fede F.
    Clin Ther; 1993 Jul 24; 15 Suppl B():2-13. PubMed ID: 7911400
    [Abstract] [Full Text] [Related]

  • 20. How do we offer clinical relief to patients with gastro-oesophageal reflux disease?
    Galmiche JP.
    Eur J Gastroenterol Hepatol; 2000 Jun 24; 12 Suppl 1():S3-6. PubMed ID: 10929891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 81.